How is the epidemiology of cardiovascular disease in developed and developing countries?
The high incidence rate of cardiovascular disease in developed and developing countries is a challenge globally in all aspect. Cardiovascular disease in Canada is the 2nd leading cause of death. About 1 in 12 (or 2.4 million) Canadian adults age 20 and over live with diagnosed heart disease and over 669,600 (3.6%).8.5% Canadian adults are living with hearts disease and 158, 700 adults are newly diagnosed with ischemic heart disease. Comparing to Kenya in east Africa with cardiovascular as a leading cause contributing to about 6-8% of deaths. This is also linked to the high prevalence of hypertension in the last 20 years
The United Kingdom is one of the developed countries, and the updated CVD statistics for the country shows that 26% of deaths in the UK occur due to CVD. Compared to Ghana cardiovascular diseases were the most prevalent contributor to mortality accounting for 14.5% of all institutional deaths, The WHO estimates that for Ghana, the probability (%) of dying from CVD, cancer, diabetes, or chronic respiratory disease between ages 30 and 70 is 20 %.
In the UK, about 7 million people are living with the disease and the rise in the ageing population may increases the prevalence rate further in the future. In contrast, Ghana is less economically developed countries, and Ofori-Asenso and Garcia (2016) have shown that compared to other countries, the sub-Saharan region is the only region where the CVD related death has increased. It is also estimated that the burden of CVD will rise and double by 2020 compared to 1990. Ghana has been identified as the second largest city with a high rate of admission due to heart disease and stroke. In 2011, stroke was declared as the third leading cause of death in the city. There is a need to analyze the difference in the management of CVD in developed and developed countries to see how treatment outcomes and preventive conditions different in these regions.